Cargando…

New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide

Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used...

Descripción completa

Detalles Bibliográficos
Autores principales: Escudero, Victor Joaquin, Mercadal, Jordi, Molina-Andújar, Alícia, Piñeiro, Gaston J., Cucchiari, David, Jacas, Adriana, Carramiñana, Albert, Poch, Esteban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479653/
https://www.ncbi.nlm.nih.gov/pubmed/37675009
http://dx.doi.org/10.3389/fneph.2022.879766
_version_ 1785101638700105728
author Escudero, Victor Joaquin
Mercadal, Jordi
Molina-Andújar, Alícia
Piñeiro, Gaston J.
Cucchiari, David
Jacas, Adriana
Carramiñana, Albert
Poch, Esteban
author_facet Escudero, Victor Joaquin
Mercadal, Jordi
Molina-Andújar, Alícia
Piñeiro, Gaston J.
Cucchiari, David
Jacas, Adriana
Carramiñana, Albert
Poch, Esteban
author_sort Escudero, Victor Joaquin
collection PubMed
description Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems, such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence.
format Online
Article
Text
id pubmed-10479653
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104796532023-09-06 New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide Escudero, Victor Joaquin Mercadal, Jordi Molina-Andújar, Alícia Piñeiro, Gaston J. Cucchiari, David Jacas, Adriana Carramiñana, Albert Poch, Esteban Front Nephrol Nephrology Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems, such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence. Frontiers Media S.A. 2022-07-08 /pmc/articles/PMC10479653/ /pubmed/37675009 http://dx.doi.org/10.3389/fneph.2022.879766 Text en Copyright © 2022 Escudero, Mercadal, Molina-Andújar, Piñeiro, Cucchiari, Jacas, Carramiñana and Poch https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nephrology
Escudero, Victor Joaquin
Mercadal, Jordi
Molina-Andújar, Alícia
Piñeiro, Gaston J.
Cucchiari, David
Jacas, Adriana
Carramiñana, Albert
Poch, Esteban
New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
title New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
title_full New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
title_fullStr New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
title_full_unstemmed New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
title_short New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
title_sort new insights into diuretic use to treat congestion in the icu: beyond furosemide
topic Nephrology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479653/
https://www.ncbi.nlm.nih.gov/pubmed/37675009
http://dx.doi.org/10.3389/fneph.2022.879766
work_keys_str_mv AT escuderovictorjoaquin newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide
AT mercadaljordi newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide
AT molinaandujaralicia newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide
AT pineirogastonj newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide
AT cucchiaridavid newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide
AT jacasadriana newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide
AT carraminanaalbert newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide
AT pochesteban newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide